AGIOS PHARMACEUTICALS INC Contracts & Agreements
73 Contracts & Agreements
- Business Finance (22 contracts)
- Business Formation (1)
- Business Operations (2)
- Human Resources (19)
- Intellectual Property (2)
- Real Estate (13)
- Uncategorized (14)
- Purchase and Sale Agreement, dated May 24, 2024, by and between the Registrant and Royalty Pharma Investments 2019 ICAV (Filed With SEC on August 1, 2024)
- Sublease Agreement, dated April 14, 2023, between the Registrant and Watershed Informatics, Inc (Filed With SEC on February 15, 2024)
- Form of Stock Option Agreement Under 2023 Stock Incentive Plan (Filed With SEC on August 3, 2023)
- Form of Restricted Stock Unit Agreement Under 2023 Stock Incentive Plan (Filed With SEC on August 3, 2023)
- Form of Restricted Stock Unit Agreement (Performance-Based) Under 2023 Stock Incentive Plan (Filed With SEC on August 3, 2023)
- Separation Agreement, dated December 16, 2022, by and between the Registrant and Richa Poddar (Filed With SEC on May 4, 2023)
- Purchase and Sale Agreement, dated October 27, 2022, by and among the Registrant (Filed With SEC on February 23, 2023)
- Letter Agreement, dated as of December 5, 2022, between the Registrant and Tsveta Milanova (Filed With SEC on February 23, 2023)
- Consulting Agreement, dated January 1, 2023, by and between the Registrant and Richa Poddar (Filed With SEC on February 23, 2023)
- Letter Agreement, dated September 16, 2022, by and between the Company and Cecilia Jones (Filed With SEC on November 3, 2022)
- Amended and Restated Severance Benefits Plan (Filed With SEC on October 7, 2022)
- Consulting Agreement, dated May 23, 2022, by and between the Company and Bruce Car (Filed With SEC on August 4, 2022)
- Letter Agreement, dated as of July 8, 2022, between the Registrant and Brian Goff (Filed With SEC on August 4, 2022)
- Form of Inducement Stock Option Agreement (Filed With SEC on August 4, 2022)
- Form of Inducement Restricted Stock Unit Agreement (Filed With SEC on August 4, 2022)
- Form of Inducement Performance Stock Unit Agreement (Filed With SEC on August 4, 2022)
- Sublease Agreement, dated July 27, 2021, between the Registrant and Prime Medicine, Inc. (64 Sidney Street) (Filed With SEC on February 24, 2022)
- Letter Agreement, dated as of July 27, 2021, between the Registrant and Chris Bowden, M.D (Filed With SEC on November 3, 2021)
- Sublease Agreement, dated July 27, 2021, between the Registrant and Prime Medicine, Inc. (38 Sidney Street) (Filed With SEC on November 3, 2021)
- Share Repurchase Agreement, dated as of March 31, 2021, by and between Agios Pharmaceuticals, Inc. and Bristol-Myers Squibb Company (Filed With SEC on April 2, 2021)
- Purchase and Sale Agreement, dated as of December 20, 2020, by and among Agios Pharmaceuticals, Inc., Servier Pharmaceuticals, LLC, and, solely for purposes of guaranteeing... (Filed With SEC on December 22, 2020)
- Royalty Purchase Agreement, dated as of June 11, 2020, by and between the Registrant and RPI 2019 Intermediate Finance Trust (Filed With SEC on July 30, 2020)
- Letter Agreement, dated as of October 7, between the Registrant and Bruce Car (Filed With SEC on April 30, 2020)
- Amendment to Master Research and Collaboration Agreement, dated as of February 5, 2020, by and among the Registrant, Celgene Corporation and Celgene RIVOT Ltd (Filed With SEC on April 30, 2020)
- Amendment I to License Agreement, dated as of March 2, 2020, by and between the Registrant and CStone Pharmaceuticals (Filed With SEC on April 30, 2020)
- Amendment II to License Agreement, dated as of March 2, 2020, by and between the Registrant and CStone Pharmaceuticals (Filed With SEC on April 30, 2020)
- Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 19, 2020)
- Letter Agreement, dated as of September 17, 2019, between the Registrant and Jonathan Biller (Filed With SEC on February 19, 2020)
- Underwriting Agreement, dated November 7, 2019, by and among Agios Pharmaceuticals, Inc., J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Cowen and Company, LLC (Filed With SEC on November 8, 2019)
- Fourth Amendment to Lease, dated as of April 11, 2019, by and between the Registrant and Forest City 88 Sidney Street, LLC (Filed With SEC on August 1, 2019)
- Third Amendment of Lease, dated as of April 11, 2019, by and between the Registrant and UP 64 Sidney Street, LLC (Filed With SEC on August 1, 2019)
- Lease, dated as of April 11, 2019, by and between the Registrant and Thirty-Eight Sidney Street Limited LLC (Filed With SEC on August 1, 2019)
- Form of Restricted Stock Unit Agreement under 2013 Stock Incentive Plan (for directors) (Filed With SEC on February 14, 2019)
- Amended and Restated Letter Agreement, dated as of August 30, 2018, between the Registrant and David P. Schenkein, M.D (Filed With SEC on November 1, 2018)
- Letter Agreement, dated as of August 30, 2018, between the Registrant and (Filed With SEC on November 1, 2018)
- Form of Restricted Stock Unit Agreement under 2013 Stock Incentive Plan (for employees) (Filed With SEC on May 4, 2018)
- First Amendment of Lease for 64 Sidney Street, dated April 11, 2018, by and between the Company and UP 64 Sidney Street LLC (Filed With SEC on April 13, 2018)
- Underwriting Agreement, dated January 18, 2018, by and among Agios Pharmaceuticals, Inc., J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Cowen and Company, LLC (Filed With SEC on January 19, 2018)
- Lease for 64 Sidney Street, dated November 17, 2017, by and between the Company and UP 64 Sidney Street LLC (Filed With SEC on November 22, 2017)
- Third Amendment to Lease for 88 Sidney Street, dated November 17, 2017, by and between the Company and Forest City 88 Sidney Street, LLC (Filed With SEC on November 22, 2017)
- AGIOS PHARMACEUTICALS, INC. 5,050,505 Shares of Common Stock Underwriting Agreement (Filed With SEC on April 19, 2017)
- AGIOS PHARMACEUTICALS, INC. 3,370,786 Shares of Common Stock Underwriting Agreement (Filed With SEC on September 15, 2016)
- AGIOS PHARMACEUTICALS, INC. Severance Benefits Plan Effective April 22, 2016 (Filed With SEC on April 22, 2016)
- [Remainder of Page Intentionally Left Blank] (Filed With SEC on February 26, 2016)
- AGIOS PHARMACEUTICALS, INC. Performance Share Unit Agreement 2013 Stock Incentive Plan NOTICE OF GRANT (Filed With SEC on February 26, 2016)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. COLLABORATION AND LICENSEAGREEMENT by and... (Filed With SEC on August 7, 2015)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisk denote omissions. COLLABORATION AND LICENSEAGREEMENT by and... (Filed With SEC on August 7, 2015)
- SECOND AMENDMENT TO LEASE (Filed With SEC on July 23, 2015)
- AGIOS PHARMACEUTICALS, INC. POLICY WITH RESPECT TO ANNUAL PERFORMANCE-BASED CASH INCENTIVES (Filed With SEC on May 11, 2015)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. [****] denotes omissions. THIRD AMENDMENT TO DISCOVERY AND DEVELOPMENT... (Filed With SEC on February 24, 2015)
- AGIOS PHARMACEUTICALS, INC. 1,986,455 Shares of Common Stock Underwriting Agreement (Filed With SEC on December 11, 2014)
- FIRSTAMENDMENT TO LEASE (Filed With SEC on November 26, 2014)
- LEASE FOR 88 SIDNEY STREET Cambridge, Massachusetts LANDLORD: FOREST CITY 88 SIDNEY,LLC TENANT: AGIOSPHARMACEUTICALS, INC. 88 SIDNEY STREET Table of Contents (Filed With SEC on September 19, 2014)
- TERMINATION OF LEASE (Filed With SEC on September 19, 2014)
- AGIOS PHARMACEUTICALS, INC. [] Shares of Common Stock Underwriting Agreement (Filed With SEC on April 21, 2014)
- AGIOS PHARMACEUTICALS, INC. [ ] Shares of Common Stock Underwriting Agreement (Filed With SEC on July 16, 2013)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. DISCOVERY AND DEVELOPMENT COLLABORATION AND... (Filed With SEC on July 16, 2013)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on July 16, 2013)
- 38 Sidney Street, Suite 2 Cambridge, MA 02139 Main: 617 ###-###-#### Fax: 617 ###-###-#### www.agios.com (Filed With SEC on July 11, 2013)
- 38 Sidney Street, Suite2 Cambridge, MA 02139 Main: 617 ###-###-#### Fax: 617 ###-###-#### www.agios.com (Filed With SEC on July 11, 2013)
- 38 Sidney Street, Suite 2 Cambridge, MA 02139 Main: 617 ###-###-#### Fax: 617 ###-###-#### www.agios.com (Filed With SEC on July 11, 2013)
- INDEMNIFICATION AGREEMENT (Filed With SEC on July 11, 2013)
- AGIOS PHARMACEUTICALS, INC. 2013 STOCK INCENTIVE PLAN (Filed With SEC on June 24, 2013)
- AGIOS PHARMACEUTICALS, INC. Incentive Stock Option Agreement Granted Under 2013 Stock Incentive Plan (Filed With SEC on June 24, 2013)
- AGIOS PHARMACEUTICALS, INC. Nonstatutory Stock Option Agreement Granted Under 2013 Stock Incentive Plan (Filed With SEC on June 24, 2013)
- AGIOS PHARMACEUTICALS, INC. 2013 EMPLOYEE STOCK PURCHASE PLAN June 15, 2013 (Filed With SEC on June 24, 2013)
- AGIOS PHARMACEUTICALS, INC. SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT November 16, 2011 TABLE OF CONTENTS (Filed With SEC on June 10, 2013)
- AGIOS PHARMACEUTICALS, INC. 2007 STOCK INCENTIVE PLAN1 (Filed With SEC on June 10, 2013)
- AGIOS PHARMACEUTICALS, INC. Incentive Stock Option Agreement Granted Under 2007 Stock Incentive Plan (Filed With SEC on June 10, 2013)
- AGIOS PHARMACEUTICALS, INC. Nonstatutory Stock Option Agreement Granted Under 2007 Stock Incentive Plan (Filed With SEC on June 10, 2013)
- 38 Sidney Street, Suite 2 Cambridge, MA 02139 Main: 617 ###-###-#### Fax: 617 ###-###-#### www.agios.com (Filed With SEC on June 10, 2013)
- THE CLARK BUILDING Cambridge, Massachusetts LANDLORD THIRTY-EIGHTSIDNEY STREET LIMITED PARTNERSHIP TENANT AGIOS PHARMACEUTICALS, INC. THE CLARK BUILDING Table of Contents (Filed With SEC on June 10, 2013)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. DISCOVERY AND DEVELOPMENT COLLABORATION AND... (Filed With SEC on June 10, 2013)
